Updates
🌟 August 2026 Issue Published: New research articles now available in our latest journal issue. Discover cutting-edge findings. Read More 📢 Call for Papers: October 2026: Submit your research for peer review. Open access publishing with global visibility. Read More 🚀 Continental Scholarly Publications: Join our new multidisciplinary research journal platform. Publishing excellence since 2024. Read More 🎯 Special Issue: Digital Health: Call for papers on digital health innovations. Submission deadline: September 15 Read More 💼 Early Career Researcher Support: Special mentorship program and reduced fees for PhD candidates and new researchers. Read More 🔬 New Research Areas Open: Now accepting submissions in AI Ethics, Climate Science, and Public Health Innovation. Read More 🌐 Global Academic Network: Connect with researchers from 65+ countries through Continental Scholarly Publications. Read More ⏰ Fast-Track Peer Review: Accelerated review process available. Get decisions within 3 weeks. Read More

Journal of Advanced Nursing and Healthcare Research

Peer-Reviewed Academic Journal
Research Article

PHARMACOTHERAPEUTIC INNOVATIONS IN CEREBROVASCULAR ACCIDENT TREATMENT: A STUDY FROM THE ABIDJAN CARDIOLOGY INSTITUTE MEDICAL ICU

Authors & Affiliations
K. Ndiaye Aissatou
Laboratory of Pharmacology, Clinical and Therapeutic Pharmacy, Côte d’Ivoire and 2Abidjan Heart Institute of Pharmacy, Côte d’Ivoire.
Michel A. Kouadio
Laboratory of Pharmacology, Clinical and Therapeutic Pharmacy, Côte d’Ivoire and 2Abidjan Heart Institute of Pharmacy, Côte d’Ivoire.
Published: November 7, 2024
Volume 12, Issue 4 (2024)
Article ID: 271
Peer-Reviewed
Open Access
Abstract

Cerebrovascular accidents (CVAs), commonly known as strokes or "brain attacks," represent acute medical emergencies characterized by the obstruction or rupture of cerebral arteries, leading to the deprivation of blood supply to specific brain regions, resulting in cerebral infarction. These incidents manifest as rapid-onset neurological deficits lasting more than 24 hours, encompassing a spectrum of symptoms indicative of brain dysfunction. Among the most prevalent manifestations are sudden onset weakness or sensory loss in facial and limb muscles, typically unilateral, along with cognitive impairments such as confusion and difficulty in speech or comprehension. Visual disturbances, gait disturbances, dizziness, severe headaches, and loss of consciousness may also occur, underscoring the diverse clinical presentations associated with CVAs (Sagui, 2007; Kemnang et al., 2019).

Full-Text Access

Open-access article — free to read and share.

Publish Your Research in This Journal

Continental Scholarly Publications applies rigorous double-blind peer review to every submission. Our expert editorial board ensures your work meets the highest standards of scholarship before reaching an international readership.

Double-Blind Review Global Indexing Fast Turnaround Open Access DOI Assigned Wide Readership
Submit a Manuscript